Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Feldman K, Aaronson K, Gu T, Ige K, Southworth E, Sanchez L, Stieglitz E. Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization. Pediatr Blood Cancer 2024;71:e30891. [PMID: 38311802 DOI: 10.1002/pbc.30891] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 12/23/2023] [Accepted: 01/15/2024] [Indexed: 02/06/2024]

For:	Feldman K, Aaronson K, Gu T, Ige K, Southworth E, Sanchez L, Stieglitz E. Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization. Pediatr Blood Cancer 2024;71:e30891. [PMID: 38311802 DOI: 10.1002/pbc.30891] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 12/23/2023] [Accepted: 01/15/2024] [Indexed: 02/06/2024]

Number

Cited by Other Article(s)

Gilje EA, Cho C. Authors' Response. Ann Allergy Asthma Immunol 2024;133:485. [PMID: 39293903 DOI: 10.1016/j.anai.2024.06.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2024] [Accepted: 06/20/2024] [Indexed: 09/20/2024]

Tong WH. Comment on "Multiple reactions during desensitization may predict decreased efficacy of PEGasparaginase chemotherapy". Ann Allergy Asthma Immunol 2024;133:484-485. [PMID: 39293902 DOI: 10.1016/j.anai.2024.05.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Accepted: 05/23/2024] [Indexed: 09/20/2024]

Tong WH. Comment on: Desensitization using PEGasparaginase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization. Pediatr Blood Cancer 2024;71:e30935. [PMID: 38433328 DOI: 10.1002/pbc.30935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2024] [Accepted: 02/15/2024] [Indexed: 03/05/2024]